Japan, Oct. 5 -- NOVARTIS AG has got intellectual property rights for 'ANTIBODY FORMULATION.' Other related details are as follows:
Application Number: JP,2023-085464
Category (FI): A61K39/395@D,A61K39/395@H,A61K39/395@N,A61K47/04,A61K47/12,A61K47/18,A61K47/26,A61K9/08,A61K9/19,A61P11/00,A61P11/06,A61P13/12,A61P19/02,A61P27/14,A61P29/00,A61P29/00,101,A61P3/10,A61P31/04,A61P37/06,A61P43/00,111,C07K16/24,C12N15/13
Stage: Grant (IP right granted following substantive examination.)
Filing Date: May 24, 2023
Publication Date: Aug. 8, 2023
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....